0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cannabis Pharmaceuticals Market Research Report 2024
Published Date: October 2024
|
Report Code: QYRE-Auto-20W18620
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Cannabis Pharmaceuticals Market Research Report 2024
BUY CHAPTERS

Global Cannabis Pharmaceuticals Market Research Report 2024

Code: QYRE-Auto-20W18620
Report
October 2024
Pages:84
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Cannabis Pharmaceuticals Market Size

The global Cannabis Pharmaceuticals market was valued at US$ 1156 million in 2023 and is anticipated to reach US$ 2865 million by 2030, witnessing a CAGR of 13.8% during the forecast period 2024-2030.

Cannabis Pharmaceuticals Market

Cannabis Pharmaceuticals Market

Cannabis pharmaceuticals refers to the development and sale of pharmaceutical drugs or medicines with compounds of cannabis plants acting as key components. The plant belongs to the Cannabaceae family of flowering plants and produces a highly popular psychoactive drug called marijuana or cannabis. The plant is indigenous to South and Central Asia. It is widely used as a recreational drug. However, in recent times, the pharmaceutical industry has invested heavily in exploring the plant and its components for their medicinal attributes. Two of the most well-researched and popular components are cannabidiol (CBD) and tetrahydrocannabinol (THC) since they are known to exhibit several therapeutic effects. Cannabis pharmaceuticals deal with exploring a combination of cannabinoids and studying their impact on diseases or health conditions under a controlled environment and in the guidance of a licensed supervisor such as a medical practitioner. Medicines produced using cannabis are available in several forms including sprays, capsules, and tablets. The medicines cannot be rolled out in the commercial market without receiving necessary approvals from regulatory bodies.
North American market for Cannabis Pharmaceuticals is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Cannabis Pharmaceuticals is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Cannabis Pharmaceuticals include Cronos Group, Jazz Pharmaceuticals, Elixinol Wellness, Trulieve, Tilray Brands, Inc., Cansortium Inc., Aurora Cannabis, Canopy Growth, Cresco Labs, Organigram, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Cannabis Pharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cannabis Pharmaceuticals.
The Cannabis Pharmaceuticals market size, estimations, and forecasts are provided in terms of sales volume (kg) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Cannabis Pharmaceuticals market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cannabis Pharmaceuticals manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Cannabis Pharmaceuticals Market Report

Report Metric Details
Report Name Cannabis Pharmaceuticals Market
Accounted market size in 2023 US$ 1156 million
Forecasted market size in 2030 US$ 2865 million
CAGR 13.8%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Sprays
  • Capsules
  • Tablets
  • Others
Segment by Application
  • Pharmacies
  • Hospitals
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Cronos Group, Jazz Pharmaceuticals, Elixinol Wellness, Trulieve, Tilray Brands, Inc., Cansortium Inc., Aurora Cannabis, Canopy Growth, Cresco Labs, Organigram
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Cannabis Pharmaceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Cannabis Pharmaceuticals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Cannabis Pharmaceuticals Market growing?

Ans: The Cannabis Pharmaceuticals Market witnessing a CAGR of 13.8% during the forecast period 2024-2030.

What is the Cannabis Pharmaceuticals Market size in 2030?

Ans: The Cannabis Pharmaceuticals Market size in 2030 will be US$ 2865 million.

Who are the main players in the Cannabis Pharmaceuticals Market report?

Ans: The main players in the Cannabis Pharmaceuticals Market are Cronos Group, Jazz Pharmaceuticals, Elixinol Wellness, Trulieve, Tilray Brands, Inc., Cansortium Inc., Aurora Cannabis, Canopy Growth, Cresco Labs, Organigram

What are the Application segmentation covered in the Cannabis Pharmaceuticals Market report?

Ans: The Applications covered in the Cannabis Pharmaceuticals Market report are Pharmacies, Hospitals, Others

What are the Type segmentation covered in the Cannabis Pharmaceuticals Market report?

Ans: The Types covered in the Cannabis Pharmaceuticals Market report are Sprays, Capsules, Tablets, Others

Recommended Reports

Cannabis Medicine

Botanical & Herbal

Cannabis Devices

1 Cannabis Pharmaceuticals Market Overview
1.1 Product Definition
1.2 Cannabis Pharmaceuticals by Type
1.2.1 Global Cannabis Pharmaceuticals Market Value Comparison by Type (2024-2030)
1.2.2 Sprays
1.2.3 Capsules
1.2.4 Tablets
1.2.5 Others
1.3 Cannabis Pharmaceuticals by Application
1.3.1 Global Cannabis Pharmaceuticals Market Value by Application (2024-2030)
1.3.2 Pharmacies
1.3.3 Hospitals
1.3.4 Others
1.4 Global Cannabis Pharmaceuticals Market Size Estimates and Forecasts
1.4.1 Global Cannabis Pharmaceuticals Revenue 2019-2030
1.4.2 Global Cannabis Pharmaceuticals Sales 2019-2030
1.4.3 Global Cannabis Pharmaceuticals Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Cannabis Pharmaceuticals Market Competition by Manufacturers
2.1 Global Cannabis Pharmaceuticals Sales Market Share by Manufacturers (2019-2024)
2.2 Global Cannabis Pharmaceuticals Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Cannabis Pharmaceuticals Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Cannabis Pharmaceuticals, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Cannabis Pharmaceuticals, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cannabis Pharmaceuticals, Product Type & Application
2.7 Global Key Manufacturers of Cannabis Pharmaceuticals, Date of Enter into This Industry
2.8 Global Cannabis Pharmaceuticals Market Competitive Situation and Trends
2.8.1 Global Cannabis Pharmaceuticals Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Cannabis Pharmaceuticals Players Market Share by Revenue
2.8.3 Global Cannabis Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Cannabis Pharmaceuticals Market Scenario by Region
3.1 Global Cannabis Pharmaceuticals Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Cannabis Pharmaceuticals Sales by Region: 2019-2030
3.2.1 Global Cannabis Pharmaceuticals Sales by Region: 2019-2024
3.2.2 Global Cannabis Pharmaceuticals Sales by Region: 2025-2030
3.3 Global Cannabis Pharmaceuticals Revenue by Region: 2019-2030
3.3.1 Global Cannabis Pharmaceuticals Revenue by Region: 2019-2024
3.3.2 Global Cannabis Pharmaceuticals Revenue by Region: 2025-2030
3.4 North America Cannabis Pharmaceuticals Market Facts & Figures by Country
3.4.1 North America Cannabis Pharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Cannabis Pharmaceuticals Sales by Country (2019-2030)
3.4.3 North America Cannabis Pharmaceuticals Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Cannabis Pharmaceuticals Market Facts & Figures by Country
3.5.1 Europe Cannabis Pharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Cannabis Pharmaceuticals Sales by Country (2019-2030)
3.5.3 Europe Cannabis Pharmaceuticals Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cannabis Pharmaceuticals Market Facts & Figures by Region
3.6.1 Asia Pacific Cannabis Pharmaceuticals Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Cannabis Pharmaceuticals Sales by Region (2019-2030)
3.6.3 Asia Pacific Cannabis Pharmaceuticals Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Cannabis Pharmaceuticals Market Facts & Figures by Country
3.7.1 Latin America Cannabis Pharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Cannabis Pharmaceuticals Sales by Country (2019-2030)
3.7.3 Latin America Cannabis Pharmaceuticals Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Cannabis Pharmaceuticals Market Facts & Figures by Country
3.8.1 Middle East and Africa Cannabis Pharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Cannabis Pharmaceuticals Sales by Country (2019-2030)
3.8.3 Middle East and Africa Cannabis Pharmaceuticals Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Cannabis Pharmaceuticals Sales by Type (2019-2030)
4.1.1 Global Cannabis Pharmaceuticals Sales by Type (2019-2024)
4.1.2 Global Cannabis Pharmaceuticals Sales by Type (2025-2030)
4.1.3 Global Cannabis Pharmaceuticals Sales Market Share by Type (2019-2030)
4.2 Global Cannabis Pharmaceuticals Revenue by Type (2019-2030)
4.2.1 Global Cannabis Pharmaceuticals Revenue by Type (2019-2024)
4.2.2 Global Cannabis Pharmaceuticals Revenue by Type (2025-2030)
4.2.3 Global Cannabis Pharmaceuticals Revenue Market Share by Type (2019-2030)
4.3 Global Cannabis Pharmaceuticals Price by Type (2019-2030)
5 Segment by Application
5.1 Global Cannabis Pharmaceuticals Sales by Application (2019-2030)
5.1.1 Global Cannabis Pharmaceuticals Sales by Application (2019-2024)
5.1.2 Global Cannabis Pharmaceuticals Sales by Application (2025-2030)
5.1.3 Global Cannabis Pharmaceuticals Sales Market Share by Application (2019-2030)
5.2 Global Cannabis Pharmaceuticals Revenue by Application (2019-2030)
5.2.1 Global Cannabis Pharmaceuticals Revenue by Application (2019-2024)
5.2.2 Global Cannabis Pharmaceuticals Revenue by Application (2025-2030)
5.2.3 Global Cannabis Pharmaceuticals Revenue Market Share by Application (2019-2030)
5.3 Global Cannabis Pharmaceuticals Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Cronos Group
6.1.1 Cronos Group Company Information
6.1.2 Cronos Group Description and Business Overview
6.1.3 Cronos Group Cannabis Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Cronos Group Cannabis Pharmaceuticals Product Portfolio
6.1.5 Cronos Group Recent Developments/Updates
6.2 Jazz Pharmaceuticals
6.2.1 Jazz Pharmaceuticals Company Information
6.2.2 Jazz Pharmaceuticals Description and Business Overview
6.2.3 Jazz Pharmaceuticals Cannabis Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Jazz Pharmaceuticals Cannabis Pharmaceuticals Product Portfolio
6.2.5 Jazz Pharmaceuticals Recent Developments/Updates
6.3 Elixinol Wellness
6.3.1 Elixinol Wellness Company Information
6.3.2 Elixinol Wellness Description and Business Overview
6.3.3 Elixinol Wellness Cannabis Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Elixinol Wellness Cannabis Pharmaceuticals Product Portfolio
6.3.5 Elixinol Wellness Recent Developments/Updates
6.4 Trulieve
6.4.1 Trulieve Company Information
6.4.2 Trulieve Description and Business Overview
6.4.3 Trulieve Cannabis Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Trulieve Cannabis Pharmaceuticals Product Portfolio
6.4.5 Trulieve Recent Developments/Updates
6.5 Tilray Brands, Inc.
6.5.1 Tilray Brands, Inc. Company Information
6.5.2 Tilray Brands, Inc. Description and Business Overview
6.5.3 Tilray Brands, Inc. Cannabis Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Tilray Brands, Inc. Cannabis Pharmaceuticals Product Portfolio
6.5.5 Tilray Brands, Inc. Recent Developments/Updates
6.6 Cansortium Inc.
6.6.1 Cansortium Inc. Company Information
6.6.2 Cansortium Inc. Description and Business Overview
6.6.3 Cansortium Inc. Cannabis Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Cansortium Inc. Cannabis Pharmaceuticals Product Portfolio
6.6.5 Cansortium Inc. Recent Developments/Updates
6.7 Aurora Cannabis
6.7.1 Aurora Cannabis Company Information
6.7.2 Aurora Cannabis Description and Business Overview
6.7.3 Aurora Cannabis Cannabis Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Aurora Cannabis Cannabis Pharmaceuticals Product Portfolio
6.7.5 Aurora Cannabis Recent Developments/Updates
6.8 Canopy Growth
6.8.1 Canopy Growth Company Information
6.8.2 Canopy Growth Description and Business Overview
6.8.3 Canopy Growth Cannabis Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Canopy Growth Cannabis Pharmaceuticals Product Portfolio
6.8.5 Canopy Growth Recent Developments/Updates
6.9 Cresco Labs
6.9.1 Cresco Labs Company Information
6.9.2 Cresco Labs Description and Business Overview
6.9.3 Cresco Labs Cannabis Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Cresco Labs Cannabis Pharmaceuticals Product Portfolio
6.9.5 Cresco Labs Recent Developments/Updates
6.10 Organigram
6.10.1 Organigram Company Information
6.10.2 Organigram Description and Business Overview
6.10.3 Organigram Cannabis Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Organigram Cannabis Pharmaceuticals Product Portfolio
6.10.5 Organigram Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cannabis Pharmaceuticals Industry Chain Analysis
7.2 Cannabis Pharmaceuticals Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cannabis Pharmaceuticals Production Mode & Process
7.4 Cannabis Pharmaceuticals Sales and Marketing
7.4.1 Cannabis Pharmaceuticals Sales Channels
7.4.2 Cannabis Pharmaceuticals Distributors
7.5 Cannabis Pharmaceuticals Customers
8 Cannabis Pharmaceuticals Market Dynamics
8.1 Cannabis Pharmaceuticals Industry Trends
8.2 Cannabis Pharmaceuticals Market Drivers
8.3 Cannabis Pharmaceuticals Market Challenges
8.4 Cannabis Pharmaceuticals Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Cannabis Pharmaceuticals Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Cannabis Pharmaceuticals Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Cannabis Pharmaceuticals Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Cannabis Pharmaceuticals Sales (kg) of Key Manufacturers (2019-2024)
 Table 5. Global Cannabis Pharmaceuticals Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Cannabis Pharmaceuticals Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Cannabis Pharmaceuticals Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Cannabis Pharmaceuticals Average Price (US$/g) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Cannabis Pharmaceuticals, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Cannabis Pharmaceuticals, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Cannabis Pharmaceuticals, Product Type & Application
 Table 12. Global Key Manufacturers of Cannabis Pharmaceuticals, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Cannabis Pharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cannabis Pharmaceuticals as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Cannabis Pharmaceuticals Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Cannabis Pharmaceuticals Sales by Region (2019-2024) & (kg)
 Table 18. Global Cannabis Pharmaceuticals Sales Market Share by Region (2019-2024)
 Table 19. Global Cannabis Pharmaceuticals Sales by Region (2025-2030) & (kg)
 Table 20. Global Cannabis Pharmaceuticals Sales Market Share by Region (2025-2030)
 Table 21. Global Cannabis Pharmaceuticals Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Cannabis Pharmaceuticals Revenue Market Share by Region (2019-2024)
 Table 23. Global Cannabis Pharmaceuticals Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Cannabis Pharmaceuticals Revenue Market Share by Region (2025-2030)
 Table 25. North America Cannabis Pharmaceuticals Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Cannabis Pharmaceuticals Sales by Country (2019-2024) & (kg)
 Table 27. North America Cannabis Pharmaceuticals Sales by Country (2025-2030) & (kg)
 Table 28. North America Cannabis Pharmaceuticals Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Cannabis Pharmaceuticals Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Cannabis Pharmaceuticals Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Cannabis Pharmaceuticals Sales by Country (2019-2024) & (kg)
 Table 32. Europe Cannabis Pharmaceuticals Sales by Country (2025-2030) & (kg)
 Table 33. Europe Cannabis Pharmaceuticals Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Cannabis Pharmaceuticals Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Cannabis Pharmaceuticals Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Cannabis Pharmaceuticals Sales by Region (2019-2024) & (kg)
 Table 37. Asia Pacific Cannabis Pharmaceuticals Sales by Region (2025-2030) & (kg)
 Table 38. Asia Pacific Cannabis Pharmaceuticals Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Cannabis Pharmaceuticals Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Cannabis Pharmaceuticals Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Cannabis Pharmaceuticals Sales by Country (2019-2024) & (kg)
 Table 42. Latin America Cannabis Pharmaceuticals Sales by Country (2025-2030) & (kg)
 Table 43. Latin America Cannabis Pharmaceuticals Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Cannabis Pharmaceuticals Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Cannabis Pharmaceuticals Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Cannabis Pharmaceuticals Sales by Country (2019-2024) & (kg)
 Table 47. Middle East and Africa Cannabis Pharmaceuticals Sales by Country (2025-2030) & (kg)
 Table 48. Middle East and Africa Cannabis Pharmaceuticals Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Cannabis Pharmaceuticals Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Cannabis Pharmaceuticals Sales (kg) by Type (2019-2024)
 Table 51. Global Cannabis Pharmaceuticals Sales (kg) by Type (2025-2030)
 Table 52. Global Cannabis Pharmaceuticals Sales Market Share by Type (2019-2024)
 Table 53. Global Cannabis Pharmaceuticals Sales Market Share by Type (2025-2030)
 Table 54. Global Cannabis Pharmaceuticals Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Cannabis Pharmaceuticals Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Cannabis Pharmaceuticals Revenue Market Share by Type (2019-2024)
 Table 57. Global Cannabis Pharmaceuticals Revenue Market Share by Type (2025-2030)
 Table 58. Global Cannabis Pharmaceuticals Price (US$/g) by Type (2019-2024)
 Table 59. Global Cannabis Pharmaceuticals Price (US$/g) by Type (2025-2030)
 Table 60. Global Cannabis Pharmaceuticals Sales (kg) by Application (2019-2024)
 Table 61. Global Cannabis Pharmaceuticals Sales (kg) by Application (2025-2030)
 Table 62. Global Cannabis Pharmaceuticals Sales Market Share by Application (2019-2024)
 Table 63. Global Cannabis Pharmaceuticals Sales Market Share by Application (2025-2030)
 Table 64. Global Cannabis Pharmaceuticals Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Cannabis Pharmaceuticals Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Cannabis Pharmaceuticals Revenue Market Share by Application (2019-2024)
 Table 67. Global Cannabis Pharmaceuticals Revenue Market Share by Application (2025-2030)
 Table 68. Global Cannabis Pharmaceuticals Price (US$/g) by Application (2019-2024)
 Table 69. Global Cannabis Pharmaceuticals Price (US$/g) by Application (2025-2030)
 Table 70. Cronos Group Company Information
 Table 71. Cronos Group Description and Business Overview
 Table 72. Cronos Group Cannabis Pharmaceuticals Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 73. Cronos Group Cannabis Pharmaceuticals Product
 Table 74. Cronos Group Recent Developments/Updates
 Table 75. Jazz Pharmaceuticals Company Information
 Table 76. Jazz Pharmaceuticals Description and Business Overview
 Table 77. Jazz Pharmaceuticals Cannabis Pharmaceuticals Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 78. Jazz Pharmaceuticals Cannabis Pharmaceuticals Product
 Table 79. Jazz Pharmaceuticals Recent Developments/Updates
 Table 80. Elixinol Wellness Company Information
 Table 81. Elixinol Wellness Description and Business Overview
 Table 82. Elixinol Wellness Cannabis Pharmaceuticals Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 83. Elixinol Wellness Cannabis Pharmaceuticals Product
 Table 84. Elixinol Wellness Recent Developments/Updates
 Table 85. Trulieve Company Information
 Table 86. Trulieve Description and Business Overview
 Table 87. Trulieve Cannabis Pharmaceuticals Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 88. Trulieve Cannabis Pharmaceuticals Product
 Table 89. Trulieve Recent Developments/Updates
 Table 90. Tilray Brands, Inc. Company Information
 Table 91. Tilray Brands, Inc. Description and Business Overview
 Table 92. Tilray Brands, Inc. Cannabis Pharmaceuticals Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 93. Tilray Brands, Inc. Cannabis Pharmaceuticals Product
 Table 94. Tilray Brands, Inc. Recent Developments/Updates
 Table 95. Cansortium Inc. Company Information
 Table 96. Cansortium Inc. Description and Business Overview
 Table 97. Cansortium Inc. Cannabis Pharmaceuticals Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 98. Cansortium Inc. Cannabis Pharmaceuticals Product
 Table 99. Cansortium Inc. Recent Developments/Updates
 Table 100. Aurora Cannabis Company Information
 Table 101. Aurora Cannabis Description and Business Overview
 Table 102. Aurora Cannabis Cannabis Pharmaceuticals Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 103. Aurora Cannabis Cannabis Pharmaceuticals Product
 Table 104. Aurora Cannabis Recent Developments/Updates
 Table 105. Canopy Growth Company Information
 Table 106. Canopy Growth Description and Business Overview
 Table 107. Canopy Growth Cannabis Pharmaceuticals Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 108. Canopy Growth Cannabis Pharmaceuticals Product
 Table 109. Canopy Growth Recent Developments/Updates
 Table 110. Cresco Labs Company Information
 Table 111. Cresco Labs Description and Business Overview
 Table 112. Cresco Labs Cannabis Pharmaceuticals Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 113. Cresco Labs Cannabis Pharmaceuticals Product
 Table 114. Cresco Labs Recent Developments/Updates
 Table 115. Organigram Company Information
 Table 116. Organigram Description and Business Overview
 Table 117. Organigram Cannabis Pharmaceuticals Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 118. Organigram Cannabis Pharmaceuticals Product
 Table 119. Organigram Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Cannabis Pharmaceuticals Distributors List
 Table 123. Cannabis Pharmaceuticals Customers List
 Table 124. Cannabis Pharmaceuticals Market Trends
 Table 125. Cannabis Pharmaceuticals Market Drivers
 Table 126. Cannabis Pharmaceuticals Market Challenges
 Table 127. Cannabis Pharmaceuticals Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Cannabis Pharmaceuticals
 Figure 2. Global Cannabis Pharmaceuticals Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Cannabis Pharmaceuticals Market Share by Type: 2023 & 2030
 Figure 4. Sprays Product Picture
 Figure 5. Capsules Product Picture
 Figure 6. Tablets Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Cannabis Pharmaceuticals Market Value by Application (2024-2030) & (US$ Million)
 Figure 9. Global Cannabis Pharmaceuticals Market Share by Application: 2023 & 2030
 Figure 10. Pharmacies
 Figure 11. Hospitals
 Figure 12. Others
 Figure 13. Global Cannabis Pharmaceuticals Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 14. Global Cannabis Pharmaceuticals Market Size (2019-2030) & (US$ Million)
 Figure 15. Global Cannabis Pharmaceuticals Sales (2019-2030) & (kg)
 Figure 16. Global Cannabis Pharmaceuticals Average Price (US$/g) & (2019-2030)
 Figure 17. Cannabis Pharmaceuticals Report Years Considered
 Figure 18. Cannabis Pharmaceuticals Sales Share by Manufacturers in 2023
 Figure 19. Global Cannabis Pharmaceuticals Revenue Share by Manufacturers in 2023
 Figure 20. Global 5 and 10 Largest Cannabis Pharmaceuticals Players: Market Share by Revenue in Cannabis Pharmaceuticals in 2023
 Figure 21. Cannabis Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 22. Global Cannabis Pharmaceuticals Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 23. North America Cannabis Pharmaceuticals Sales Market Share by Country (2019-2030)
 Figure 24. North America Cannabis Pharmaceuticals Revenue Market Share by Country (2019-2030)
 Figure 25. United States Cannabis Pharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Canada Cannabis Pharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 27. Europe Cannabis Pharmaceuticals Sales Market Share by Country (2019-2030)
 Figure 28. Europe Cannabis Pharmaceuticals Revenue Market Share by Country (2019-2030)
 Figure 29. Germany Cannabis Pharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. France Cannabis Pharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. U.K. Cannabis Pharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Italy Cannabis Pharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Russia Cannabis Pharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Asia Pacific Cannabis Pharmaceuticals Sales Market Share by Region (2019-2030)
 Figure 35. Asia Pacific Cannabis Pharmaceuticals Revenue Market Share by Region (2019-2030)
 Figure 36. China Cannabis Pharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. Japan Cannabis Pharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. South Korea Cannabis Pharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. India Cannabis Pharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Australia Cannabis Pharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. China Taiwan Cannabis Pharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Southeast Asia Cannabis Pharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Latin America Cannabis Pharmaceuticals Sales Market Share by Country (2019-2030)
 Figure 44. Mexico Cannabis Pharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Brazil Cannabis Pharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Argentina Cannabis Pharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Colombia Cannabis Pharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Middle East and Africa Cannabis Pharmaceuticals Sales Market Share by Country (2019-2030)
 Figure 49. Middle East and Africa Cannabis Pharmaceuticals Revenue Market Share by Country (2019-2030)
 Figure 50. Turkey Cannabis Pharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Saudi Arabia Cannabis Pharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. UAE Cannabis Pharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 53. Global Sales Market Share of Cannabis Pharmaceuticals by Type (2019-2030)
 Figure 54. Global Revenue Market Share of Cannabis Pharmaceuticals by Type (2019-2030)
 Figure 55. Global Cannabis Pharmaceuticals Price (US$/g) by Type (2019-2030)
 Figure 56. Global Sales Market Share of Cannabis Pharmaceuticals by Application (2019-2030)
 Figure 57. Global Revenue Market Share of Cannabis Pharmaceuticals by Application (2019-2030)
 Figure 58. Global Cannabis Pharmaceuticals Price (US$/g) by Application (2019-2030)
 Figure 59. Cannabis Pharmaceuticals Value Chain
 Figure 60. Cannabis Pharmaceuticals Production Process
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS